fully human monoclonal antibody combination (Vanderbilt University Medical Center/IDBiologics)

N/A

Report date: 2025/01/26 18:49:33

Base Information

Drug Namefully human monoclonal antibody combination (Vanderbilt University Medical Center/IDBiologics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesIDBiologics IncVanderbilt University Medical Center
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A